Apimeds Pharmaceuticals US, Inc. [APUS] - appoints Eric Sherb as CFO
Effective October 1, 2026, Eric Sherb has been appointed as Chief Financial Officer of Apimeds Pharmaceuticals US, Inc., succeeding Interim CFO Erick Frim, who resigned on September 29, 2026.
Why this matters
Apimeds Pharmaceuticals US, Inc., a Delaware-incorporated company in the pharmaceutical preparations industry, focuses on developing and manufacturing medications for various health conditions. On October 1, 2026, Eric Sherb was appointed as the new Chief Financial Officer, following the resignation of Interim CFO Erick Frim on September 29, 2026. This appointment was formalized through an Executive Employment Agreement, which includes a base salary of $60,000 per year, excluding potential future equity-based compensation. There are no disclosed arrangements or transactions involving Mr. Sherb that require reporting, and he has no familial ties to the company's board or executive officers.